Evgenia Ostroumova Selected Research

Iodine-131

1/2021	Lessons learned from Chernobyl and Fukushima on thyroid cancer screening and recommendations in case of a future nuclear accident.
5/2016	Non-thyroid cancer incidence in Belarusian residents exposed to Chernobyl fallout in childhood and adolescence: Standardized Incidence Ratio analysis, 1997-2011.
8/2015	Thyroid Dose Estimates for a Cohort of Belarusian Children Exposed to (131)I from the Chernobyl Accident: Assessment of Uncertainties.
2/2015	Analysis of thyroid malignant pathologic findings identified during 3 rounds of screening (1997-2008) of a cohort of children and adolescents from belarus exposed to radioiodines after the Chernobyl accident.
1/2014	Impact of uncertainties in exposure assessment on estimates of thyroid cancer risk among Ukrainian children and adolescents exposed from the Chernobyl accident.
5/2009	Subclinical hypothyroidism after radioiodine exposure: Ukrainian-American cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident (1998-2000).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evgenia Ostroumova Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 02/2015
7	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 01/2014
4	Thyroid Diseases (Thyroid Disease) 10/2019 - 07/2013
3	Hypothyroidism 01/2018 - 05/2009
1	Hyperthyroidism 01/2019
1	Leukemia 05/2016
1	Thyroiditis 07/2013
1	Thyroid Nodule (Nodule, Thyroid) 07/2013
1	Graves Disease (Basedow Disease) 07/2013

Drug/Important Bio-Agent (IBA)

6	Iodine-131IBA 01/2021 - 05/2009
3	IodineIBA 10/2019 - 07/2013
2	Serpentine Asbestos (Chrysotile)IBA 01/2020 - 01/2020
1	Biological ProductsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ORALIT (ORS)IBA 01/2019
1	Alkylating AgentsIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Lomustine (CCNU)FDA Link 01/2018
1	Radioactive Fallout (Fallout, Radioactive)IBA 03/2014
1	AutoantibodiesIBA 07/2013
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2013
1	AntibodiesIBA 05/2009

Therapy/Procedure

2	Radiotherapy 01/2019 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2018
1	Nuclear Power Plants 01/2014